Goosehead to Restate FY2023-FY2025 and 2026 Interim Financials; Q3 10-Q Delayed
GSHD sits 62% above its 52-week low of $33.68.
Summary
Goosehead will restate financials for FY2023 through Q2 2026 after the SEC flagged two accounting departures. Management expects material weaknesses in internal controls and will miss the November 9 deadline for its Q3 10-Q. Preliminary Q3 revenue grew about 17%, and full-year guidance was reaffirmed.
Key Events · Legal and Risk Events · GSHD
-
Three Years of Financials Restated
Following an SEC comment letter on contract-acquisition cost accounting, the Audit Committee concluded on November 6, 2026 that FY2023, FY2024 and FY2025 audited statements plus interim periods through Q2 2026 should no longer be relied upon.
-
Two GAAP Departures Quantified
Commission expensing under ASC 340-40 overstated employee compensation and understated operating income by roughly 0.5% to 5.5% of employee comp. Separately, franchisee technology and E&O fees were netted against G&A instead of booked as revenue—a reclassification that adds $11M-$16M to both revenue and G&A for FY2025 and $5.5M-$8.5M for the six months ended June 30, 2026.
-
Material Weaknesses Expected
Management expects to report one or more material weaknesses in internal control over financial reporting and to conclude that disclosure controls and procedures were not effective for each non-reliance period.
-
Q3 10-Q Deadline Missed
The Q3 2026 Form 10-Q will not be filed by the November 9, 2026 due date. Amendments on Form 10-K/A and 10-Q/A will be filed as soon as practicable, with no stated timeline.
Analysis · GSHD · Finance
An SEC comment letter exposed two GAAP departures, and now three years of audited financials plus every interim period through Q2 2026 can no longer be relied upon. The commission-expensing fix actually helps reported operating income, lifting it by 0.5%-5.5% of employee comp. The franchise-fee fix, by contrast, is a pure gross-up of revenue and G&A with no profit or cash effect. Still, the credibility cost is real: management expects one or more material weaknesses in internal control and says disclosure controls were not effective. The Q3 10-Q will miss its November 9 due date, which puts the company on the path toward Nasdaq's delinquency process if the restatement drags. Preliminary Q3 revenue of $108.8M-$110.8M (~17% growth) and reaffirmed full-year guidance show the underlying business is intact; the open question is how long the restatement and remediation take.
How filings like this one have moved
In the 30 days to Nov 11, 2026, 52.1% of the 217 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.69%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, GSHD was trading at $54.69 on NASDAQ in the Finance sector, with a market capitalization of approximately $1.9B. The 52-week trading range was $33.68 to $79.85. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.